--- title: "Australia-Based CRO for Biotechs | Go Global | Avance Clinical" description: "Accelerate early-phase research and global approval with experts across 250+ indications. Avance Clinical, the Australia-based CRO for biotechs." canonical: "https://www.avancecro.com/" generated: "2026-08-27T01:13:05+00:00" --- **The Australia-Based CRO for Biotechs** # The Fastest Path **From Preclinical to Global Approval** Starts in [Australia](https://www.avancecro.com/the-australian-advantage/) Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia, with operations across [North America](https://www.avancecro.com/the-north-american-advantage/), [Asia](https://www.avancecro.com/the-asia-advantage/) Pacific, China and Europe and 30+ years of deep clinical research management. **Move seamlessly from preclinical planning to global approval with experts who preserve your time, budget, and institutional knowledge every step of the way.** [Request a proposal](https://www.avancecro.com/request-a-proposal/) ### FROST & SULLIVAN GLOBAL CRO OF THE YEAR 2026 [Read more](https://www.avancecro.com/news/frost-sullivans-2026-global-company-of-the-year) ### FROST & SULLIVAN BIOTECH CRO EXCELLENCE 2025 [Learn more](https://www.avancecro.com/news/avance-clinical-honored-with-frost-sullivans-2025-global-customer-value-leadership-award-for-transformative-biotech-cro-services/) ## Why Biotechs Choose to **Go Global with Avance Clinical** ### Globally Accepted Data Every study is structured to meet FDA, EMA, TGA, and all major regulatory authority standards from your first protocol onward. ### In-House Scientific & Regulatory Affairs Avance Clinical is one of the few mid-sized global CROs with an in-house regulatory affairs team, which means you get cross-functional strategy instead of a hand-off between vendors. ### Expertise Across 250+ Therapeutic Indications Deep experience across [Early Phase](https://www.avancecro.com/early-phase-center-of-excellence-for-biotechs), [CNS](https://www.avancecro.com/expert-clinical-trial-services-in-neuroscience), [Oncology](https://www.avancecro.com/oncology-center-of-excellence/), and [Renal and Metabolic](https://www.avancecro.com/renal-cardiometabolic-center-of-excellence/) disorders, backed by specialized Centers of Excellence, including a dedicated U.S. oncology team. ### Australian Rapid Start-Up & **43.5% Savings Potential** Site Initiation Visit (SIV) and Study Start in as little as 5-6 weeks. No IND required. 280+ Phase III trials began with an Australian [Phase I](https://www.avancecro.com/cro/phase-i-early-phase/). Clinical trial spend stretches further with the R&D rebate potential (up to 43.5%). [Learn more](https://www.avancecro.com/the-australian-advantage/) ![](https://www.avancecro.com/wp-content/uploads/2026/08/iStock-2218786594-2-aspect-ratio-1600-975-916x916.jpg) ### ![2026 Frost & Sullivan Global Biotechnology CRO Company of the Year](https://www.frost.com/wp-content/uploads/2026/05/FS_logo_wh_112524.webp) **2026 Global Biotechnology CRO Company of the Year** [Learn more](https://www.avancecro.com/news/frost-sullivans-2026-global-company-of-the-year/) ## **One Global Delivery Model**. Proven for Every Development Phase Whether you’re still generating preclinical data or scaling into Phase III, Avance Clinical carries the same team, systems, and data standards forward at every stage. Across a vast operational network, cross-disciplinary teams quickly become deeply expert in your science, forming a single point of accountability across every strategic and executional stage of development. ![](https://www.avancecro.com/wp-content/uploads/2026/08/Asia-map-aspect-ratio-1600-975-916x916.jpg) ## Clinical Research Solutions ### **ClinicReady** Our in-house scientific and regulatory affairs specialists work with you before study design begins, so every preclinical study generates data that supports your IND package and sets up your transition to [Phase I](https://www.avancecro.com/cro/phase-i-early-phase/). ### Scientific & Regulatory Affairs The most experienced global team ### Surrogate Drug Development Team Your outsourced roadmap experts ### Proof of Concept Start with the right data ### Global Expertise Across the latest regulatory updates [Learn more about ClinicReady](https://www.avancecro.com/cro/preclinical-clinicready/) ### **GlobalReady** Start in [Australia](https://www.avancecro.com/the-australian-advantage/), then move into [North America](https://www.avancecro.com/the-north-american-advantage/), [Asia](https://www.avancecro.com/the-asia-advantage/) Pacific, or Europe with the same team, systems, and data standards. No hand-offs, no re-onboarding a new CRO mid-program. ### Robust Foundations Early planning built for later-phase roll-out ### Seamless Journey One team, no hand-offs, no re-onboarding ### U.S. Oncology Continuity The only Australian-headquartered CRO with a dedicated U.S. oncology team ### Quality Data Track record of success with FDA, EMA, and other major regulators [Learn more about GlobalReady](https://www.avancecro.com/cro/globalready/) ### **[Phase I](https://www.avancecro.com/cro/phase-i-early-phase/) / [Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/)** From comprehensive preclinical services to Phase I trials, Avance Clinical delivers fast, agile, and adaptive clinical research solutions for biotechs in the early phases of development. ### First-In-Human Ready Built for the studies that matter most ### Rapid & Agile Time and funds are key priorities ### Data That Validates Strategic endpoints support a strong data package ### 43.5% Rebate Potential Across all phases [Learn more about Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/) ### **Phase II+ / [Late phase](https://www.avancecro.com/cro/phase-ii-late-phase/)** Multi-regional clinical excellence across 250+ therapeutic indications, backed by the latest technology, AI, RWD, and RWE, as well as gold standard systems and processes. ### Multi-Regional Expand globally with the same team ### Oncology, CNS, Renal and Metabolic, & More Deep expertise across key therapeutic areas ### Gold Standard Systems & Processes The latest AI tools plus industry-standard systems ### One CRO Across All Phases Built for success at every stage [Learn more about Late Phase](https://www.avancecro.com/cro/phase-ii-late-phase/) ## Proven industry **experience & expertise** ### 30 Years of CRO experience ### 500+ Studies in the past 5 years ### 450+ Experienced team members ### 18k+ Participants past 5 years [View our capabilities](https://www.avancecro.com/capabilities/our-capabilities/) ### Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026 Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region. [Learn more](https://www.avancecro.com/news/avance-clinical-announces-asia-pacific-and-mainland-china-expansion-ahead-of-bio-international-convention-2026/) ![Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026](https://www.avancecro.com/wp-content/uploads/2026/06/Singapore-aspect-ratio-40-27-1-800x800.jpg) ### Frost & Sullivan’s 2026 Global Company of the Year Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact. [Learn more](https://www.avancecro.com/news/frost-sullivans-2026-global-company-of-the-year/) ![Frost & Sullivan’s 2026 Global Company of the Year](https://www.avancecro.com/wp-content/uploads/2026/05/Avance-Clinical-BPR-Logo-2-1000x1000.png) ### AusBiotech International Conference 2026 | Early-Phase CRO for Biotechs 20 – 23 October 2026 Avance Clinical is exhibiting at AusBiotech International Conference 2026 on the Gold Coast. Book a meeting [Learn more](https://www.avancecro.com/events/ausbiotech-international-2026/) ![AusBiotech International Conference 2026 | Early-Phase CRO for Biotechs](https://www.avancecro.com/wp-content/uploads/2026/07/Gold-Coast-aspect-ratio-40-27-600x600.jpg) ### SITC 2026 | Booth 532 | Oncology CRO for Biotechs 6 – 8 November 2026 Avance Clinical, an oncology-focused CRO for biotechs, is exhibiting at SITC 2026 (Nov 6–8, Phoenix), Booth 532. Book a meeting to discuss your immuno-oncology program. Book a meeting [Learn more](https://www.avancecro.com/events/avance-clinical-at-sitc-2026-booth-532-oncology-cro-for-biotechs/) ![SITC 2026 | Booth 532 | Oncology CRO for Biotechs](https://www.avancecro.com/wp-content/uploads/2026/07/Phoenix-AZ-aspect-ratio-40-27-600x600.jpg) ### Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy Avance Clinical today announced the appointment of Tim Schuckman as its first Chief Commercial Officer (CCO). [Learn more](https://www.avancecro.com/news/avance-clinical-appoints-inaugural-chief-commercial-officer-reinforcing-global-growth-strategy/) ![Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy](https://www.avancecro.com/wp-content/uploads/2026/08/tim-schuckman-1-800x800.png) ## Position Your Asset for **Global Success** Partner with a biotech CRO that understands how to quickly and strategically leverage your program’s science. Avance Clinical’s experts work with your team to build a right-sized development pathway, from first-in-human studies to global approval. [Request a proposal](https://www.avancecro.com/request-a-proposal/)